Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Wayne Holman, Ridgeback Capital Like Sangamo Biosciences

Wayne Holman, Ridgeback Capital: Wayne Holman’s hedge fund Ridgeback Capital Management recently disclosed the purchasing of some 3.6 million shares of Sangamo Biosciences, Inc. (NASDAQ:SGMO), a filing with the SEC revealed. In this way, Ridgeback Capital Management initiated a position in the company by acquiring 5.9% of its shares, with the value of the stake amounting to almost $38.8 million.

Disclosure: none